Author: Sander Timmer

PhD student in computational genetics at Cambridge University and EMBL-European Bioinformatics Institute
Interesting read about the pros and cons about working from home (thanks +Filipe Cadete for sharing this!) in the +The New York Times. In essence working from home promotes productivity and working at the office promotes creativity.

Interesting read about the pros and cons about working from home (thanks +Filipe Cadete for sharing this!) in the +The New York Times. In essence working from home promotes productivity and working at the office promotes creativity.

It's exciting to see how big tech companies like Google/Facebook and now also Yahoo try to make life at campus as great as possible to sort of getting you hooked on getting to work. Also by limiting your desk space and closing doors at work to increase serendipitous encounters.

http://goo.gl/fpjLu

http://goo.gl/fpjLu

Interesting read about the pros and cons about working from home (thanks +Filipe…

Interesting read about the pros and cons about working from home (thanks +Filipe…

Interesting read about the pros and cons about working from home (thanks +Filipe Cadete for sharing this!) in the +The New York Times. In essence working from home promotes productivity and working at the office promotes creativity. 

It's exciting to see how big tech companies like Google/Facebook and now also Yahoo try to make life at campus as great as possible to sort of getting you hooked on getting to work. Also by limiting your desk space and closing doors at work to increase serendipitous encounters.  

http://goo.gl/fpjLu

Embedded Link

http://goo.gl/fpjLu

Untitled

Untitled

TB vaccine takes a tumble
A leading candidate for a sorely needed new vaccine against tuberculosis (TB) has failed to protect children against the disease in a major clinical trial.
Published today in The Lancet, the results of the trial of the MVA85A vaccine show that it seems to have “no significant efficacy” against either TB or infection with Mycobacterium tuberculosis.
The results are a major blow to the TB research community, as MVA85A had seemed highly promising as…

Embedded Link

TB vaccine takes a tumble
A leading candidate for a sorely needed new vaccine against tuberculosis (TB) has failed to protect children against the disease in a major clinical trial.
Published today in The Lancet, the results of the trial of the MVA85A vaccine show that it seems to have “no significant efficacy” against either TB or infection with Mycobacterium tuberculosis.
The results are a major blow to the TB research community, as MVA85A had seemed highly promising as…